MYC amplification (MYC amp), however, is well established to play a diagnostic and prognostic role in several other malignancies, including medulloblastoma, chondrosarcoma, and post-radiation cutaneous angiosarcoma, in which it imparts a poor prognosis11–14. Here, MYC is linked to chondrosarcoma.